Home

βήμα Σίγουρος δυναστεία 10.1097 fpc.0b013e3282f60aad με τον καιρό Αγνή Γκρέι Εξαγωγή

PDF) Association of Drug-Metabolizing Enzyme and Transporter Gene  Polymorphisms and Lipid-Lowering Response to Statins in Thai Patients with  Dyslipidemia
PDF) Association of Drug-Metabolizing Enzyme and Transporter Gene Polymorphisms and Lipid-Lowering Response to Statins in Thai Patients with Dyslipidemia

Association of Drug-Metabolizing Enzyme and Transporter Gene Polymorphisms  and Lipid-Lowering Response to Statins in Thai Patients with Dyslipidemia.  - Document - Gale Academic OneFile
Association of Drug-Metabolizing Enzyme and Transporter Gene Polymorphisms and Lipid-Lowering Response to Statins in Thai Patients with Dyslipidemia. - Document - Gale Academic OneFile

Full article: Association of Drug-Metabolizing Enzyme and Transporter Gene  Polymorphisms and Lipid-Lowering Response to Statins in Thai Patients with  Dyslipidemia
Full article: Association of Drug-Metabolizing Enzyme and Transporter Gene Polymorphisms and Lipid-Lowering Response to Statins in Thai Patients with Dyslipidemia

PDF) Association of Drug-Metabolizing Enzyme and Transporter Gene  Polymorphisms and Lipid-Lowering Response to Statins in Thai Patients with  Dyslipidemia
PDF) Association of Drug-Metabolizing Enzyme and Transporter Gene Polymorphisms and Lipid-Lowering Response to Statins in Thai Patients with Dyslipidemia

Association of Drug-Metabolizing Enzyme and Transporter Gene Polymorphisms  and Lipid-Lowering Response to Statins in Thai Patients with Dyslipidemia.  - Document - Gale Academic OneFile
Association of Drug-Metabolizing Enzyme and Transporter Gene Polymorphisms and Lipid-Lowering Response to Statins in Thai Patients with Dyslipidemia. - Document - Gale Academic OneFile

Association of Drug-Metabolizing Enzyme and Transporter Gene Polymorphisms  and Lipid-Lowering Response to Statins in Thai Patients with Dyslipidemia.  - Document - Gale Academic OneFile
Association of Drug-Metabolizing Enzyme and Transporter Gene Polymorphisms and Lipid-Lowering Response to Statins in Thai Patients with Dyslipidemia. - Document - Gale Academic OneFile

Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment  Equations | Circulation
Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations | Circulation

Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment  Equations | Circulation
Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations | Circulation

PDF) Association of Drug-Metabolizing Enzyme and Transporter Gene  Polymorphisms and Lipid-Lowering Response to Statins in Thai Patients with  Dyslipidemia
PDF) Association of Drug-Metabolizing Enzyme and Transporter Gene Polymorphisms and Lipid-Lowering Response to Statins in Thai Patients with Dyslipidemia

PDF) Association of Drug-Metabolizing Enzyme and Transporter Gene  Polymorphisms and Lipid-Lowering Response to Statins in Thai Patients with  Dyslipidemia
PDF) Association of Drug-Metabolizing Enzyme and Transporter Gene Polymorphisms and Lipid-Lowering Response to Statins in Thai Patients with Dyslipidemia

Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment  Equations | Circulation
Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations | Circulation

Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment  Equations | Circulation
Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations | Circulation

Apolipoprotein E genotypes and response of plasma lipids and  progression–regression of coronary atherosclerosis to lipid-lowering drug  therapy | Journal of the American College of Cardiology
Apolipoprotein E genotypes and response of plasma lipids and progression–regression of coronary atherosclerosis to lipid-lowering drug therapy | Journal of the American College of Cardiology

PDF) Association of Drug-Metabolizing Enzyme and Transporter Gene  Polymorphisms and Lipid-Lowering Response to Statins in Thai Patients with  Dyslipidemia
PDF) Association of Drug-Metabolizing Enzyme and Transporter Gene Polymorphisms and Lipid-Lowering Response to Statins in Thai Patients with Dyslipidemia

Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment  Equations | Circulation
Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations | Circulation

Frontiers | Identifying Common Genetic Risk Factors of Diabetic Neuropathies
Frontiers | Identifying Common Genetic Risk Factors of Diabetic Neuropathies

Comparison between Atorvastatin and Rosuvastatin on Secondary Percutaneous  Coronary Intervention Rate and the Risk Factors in Patients with Coronary  Heart Disease | Bentham Science
Comparison between Atorvastatin and Rosuvastatin on Secondary Percutaneous Coronary Intervention Rate and the Risk Factors in Patients with Coronary Heart Disease | Bentham Science

Frontiers | Identifying Common Genetic Risk Factors of Diabetic Neuropathies
Frontiers | Identifying Common Genetic Risk Factors of Diabetic Neuropathies

Apolipoprotein E epsilon-4 polymorphism is associated with younger age at  referral to a lipidology clinic and a poorer response to lipid-lowering  therapy | Lipids in Health and Disease | Full Text
Apolipoprotein E epsilon-4 polymorphism is associated with younger age at referral to a lipidology clinic and a poorer response to lipid-lowering therapy | Lipids in Health and Disease | Full Text